Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-26 Sale | 2024-06-27 8:00 pm | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 4,163 | $4.75 | $19,774 | 60,187 (Direct) | View |
| 2024-05-31 Sale | 2024-06-03 8:00 pm | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 1,786 | $6.09 | $10,877 | 64,350 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 4:04 pm | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 1,227 | $6.74 | $8,270 | 86,636 (Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 60 | $28.54 | $1,712 | 11,883 (Direct) | View |
| 2022-10-26 Sale | 2022-10-28 4:15 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 194 | $6.51 | $1,263 | 2,418 (Direct) | View |
| 2022-06-27 Sale | 2022-06-29 8:12 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 2,613 | $0.37 | $967 | 130,595 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 8:00 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 2,850 | $1.3 | $3,705 | 286,208 (Direct) | View |
| 2021-10-26 Sale | 2021-10-28 8:04 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 9,449 | $1.8 | $17,008 | 136,058 (Direct) | View |
| 2021-06-28 Sale | 2021-06-29 5:26 pm | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 2,452 | $5.77 | $14,148 | 145,507 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 4:04 pm | N/A 2034-01-03 | KALA BIO Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 25,100 | $0 | 86,636 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 8:00 pm | N/A 2033-06-21 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 84,336 | $0 | 110,955 (Direct) | View |
| 2023-05-31 Disposition | 2023-06-02 8:00 pm | N/A 2025-06-17 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 14,736 | $0 | 26,619 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 14,736 | $0 | 26,619 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 432 | $0 | 432 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-06 8:00 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 9,525 | $0 | 11,883 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:00 pm | N/A 2032-01-03 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER | 153,000 | $0 | 286,208 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-05 4:48 pm | N/A 2031-01-03 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 113,333 | $0 | 238,626 (Direct) | View |
| 2020-10-26 Option Award | 2020-10-28 8:22 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 61,000 | $0 | 125,293 (Direct) | View |
| 2020-06-25 Option Award | 2020-06-29 9:56 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 16,000 | $0 | 64,293 (Direct) | View |
| 2020-06-09 Exercise | 2020-06-11 4:58 pm | N/A 2024-10-01 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 43,477 | $0 | 48,293 (Direct) | View |
| 2020-06-09 Exercise | 2020-06-11 4:58 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 5,077 | $5.21 | 48,293 (Direct) | View |
| 2020-06-09 Exercise | 2020-06-11 4:58 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 26,880 | $2.3 | 48,293 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 4:11 pm | N/A 2030-01-01 | Kala Pharmaceuticals Inc. | KALA | Reumuth Mary Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |